According to studies by Guoyong Ren and Han Weina, the sustained administration of GLP-1 analogs significantly diminishes depression and anxiety-like behaviors in mice [75,76], suggesting that the anxiolytic effects of GLP-1 therapy are linked to its long-term use
This is substantially higher than with the highest dose of Rybelsus, where people lost an average of 4% of body weight
This question comes up constantly, and the honest answer depends on individual factors
43 Currently, these drugs are primarily in the development and clinical trial stages, but preliminary research results have shown their potential powerful effects in reducing blood sugar and body weight
the average regain of total body weight, fat mass, and lean mass following discontinuation of GLP-1 receptor agonists, with timelines based on key clinical trials (STEP 1 and SURMOUNT)
Learn more